Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03839693 · ClinicalTrials.gov registry record · Phase 2
ET-01 in Subjects With Lateral Canthal Lines, LCL-208
A Phase 2 study, sponsored by Eirion Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 75
- Enrollment target
NCT03839693: Completed Phase 2 study, sponsored by Eirion Therapeutics.
NCT03839693 is a Phase 2 study that has completed, run by Eirion Therapeutics. The registered enrollment target is 75 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03839693, a Phase 2 study, has completed, sponsored by Eirion Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 75 participants
- Enrollment target
Study Summary
This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).
Primary Outcome
Investigators Global Assessment of the Crow's Feet Wrinkle Scale where severity is scored between 0-4 (0=absent; 4=severe). Response is defined as change by at least two ordinals from Baseline to Week 4.
Interventions
- BIOLOGICAL Vehicle
- BIOLOGICAL botulinum toxin, Type A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2018-10-16 |
| Est. Completion | 2019-09-19 |
| Phase | Phase 2 |
What the finished NCT03839693 record still lists
NCT03839693 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% lower).
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT03839693 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03839693 about?
NCT03839693 is a clinical study titled "ET-01 in Subjects With Lateral Canthal Lines, LCL-208". This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).
What is the current status of trial NCT03839693?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2018-10-16. Estimated completion is 2019-09-19.
What interventions are being tested in trial NCT03839693?
The interventions under investigation include: Vehicle (BIOLOGICAL), botulinum toxin, Type A (BIOLOGICAL).
Who is sponsoring clinical trial NCT03839693?
This trial is sponsored by Eirion Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03839693's enrollment target sits among peer trials
75 900th of 2000 higher than 1,081 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI